Suspension of trading

Income Statement Cidara Therapeutics

Stocks

CDTX

US1717572069

Delayed Nasdaq 16:00:00 2026-01-06 EST			5-day change	1st Jan Change
221.38 ^USD	+0.03%		-.--%	+0.22%

01-08	Cidara Therapeutics, Inc.(NasdaqCM:CDTX) dropped from Russell 2000 Value Benchmark	CI
01-08	Cidara Therapeutics, Inc.(NasdaqCM:CDTX) dropped from Russell 2500 Value Benchmark	CI

834bc6ce48a5bb2fc797b9d.lhK4DClC5-_7ZHqkLbqsWoTK2SJ76CxjwxrPRcemF2c.oU3-VX0Fn8LLUBz3aIicFs-AjHI9gGIQnH6HBI_3TTbnKu9BXSefrbYdCQ

Published financial data: CIDARA THERAPEUTICS

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020 (USD)	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)
Revenues	12.07M	49.57M	64.29M	63.9M	1.28M
Total Revenues	12.07M	49.57M	64.29M	63.9M	1.28M
Cost of Goods Sold, Total	68.02M	73.09M	75.52M	70.06M	71.88M
Gross Profit	-55.95M	-23.52M	-11.23M	-6.15M	-70.6M
Selling General & Admin Expenses, Total	15.9M	18.74M	18.49M	18.33M	20.62M
R&D Expenses	-	-	-	-	-
Other Operating Expenses, Total	15.9M	18.74M	18.49M	18.33M	20.62M
Operating Income	-71.85M	-42.26M	-29.72M	-24.48M	-91.22M
Interest Expense, Total	-262K	-212K	-	-	-
Interest And Investment Income	-	-	191K	2M	5.81M
Net Interest Expenses	-262K	-212K	191K	2M	5.81M
Other Non Operating Income (Expenses)	-	-	-	-	-
EBT, Excl. Unusual Items	-72.11M	-42.47M	-29.53M	-22.49M	-85.41M
In Process R&D Expenses	-	-	-	-	-84.88M
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	-72.11M	-42.47M	-29.53M	-22.49M	-170M
Income Tax Expense	-	-	272K	443K	-
Earnings From Continuing Operations	-72.11M	-42.47M	-29.8M	-22.93M	-170M
Earnings Of Discontinued Operations	-	-	-	-	464K
Net Income to Company	-72.11M	-42.47M	-29.8M	-22.93M	-170M
Net Income - (IS)	-72.11M	-42.47M	-29.8M	-22.93M	-170M
Preferred Dividend and Other Adjustments	2.76M	-	-	-	-
Net Income to Common Incl Extra Items	-74.87M	-42.47M	-29.8M	-22.93M	-170M
Net Income to Common Excl. Extra Items	-74.87M	-42.47M	-29.8M	-22.93M	-170M
Per Share Items
Net EPS - Basic	-36.03	-16.19	-8.53	-5.25	-26.75
Basic EPS - Continuing Operations	-36.03	-16.19	-8.53	-5.25	-26.82
Basic Weighted Average Shares Outstanding	2.08M	2.62M	3.49M	4.37M	6.35M
Net EPS - Diluted	-36.03	-16.19	-8.6	-5.25	-26.75
Diluted EPS - Continuing Operations	-36.03	-16.19	-8.6	-5.25	-26.82
Diluted Weighted Average Shares Outstanding	2.08M	2.62M	3.49M	4.37M	6.35M
Normalized Basic EPS	-21.69	-10.12	-5.28	-3.22	-8.41
Normalized Diluted EPS	-21.69	-10.12	-5.28	-3.22	-8.41
Supplemental Items
EBITDA	-71.56M	-42.07M	-29.58M	-24.37M	-90.99M
EBITA	-71.85M	-42.26M	-29.72M	-24.48M	-91.22M
EBIT	-71.85M	-42.26M	-29.72M	-24.48M	-91.22M
EBITDAR	-70.56M	-40.87M	-28.28M	-22.77M	-89.29M
Total Revenues (As Reported)	12.07M	49.57M	64.29M	63.9M	1.28M
Effective Tax Rate - (Ratio)	-	-	-0.92	-1.97	-
Current Domestic Taxes	-	-	-	443K	-
Total Current Taxes	-	-	-	443K	-
Normalized Net Income	-45.07M	-26.54M	-18.45M	-14.06M	-53.38M
Interest on Long-Term Debt	21K	12K	2K	-	-
Supplemental Operating Expense Items
General and Administrative Expenses	15.9M	18.74M	18.49M	-	20.62M
Research And Development Expense From Footnotes	68.02M	73.09M	75.52M	68.53M	71.88M
Net Rental Expense, Total	1M	1.2M	1.3M	1.6M	1.7M
Imputed Operating Lease Interest Expense	213K	313K	-	-	-
Imputed Operating Lease Depreciation	787K	887K	-	-	-
Stock-Based Comp., COGS (Total)	2.09M	1.91M	1.76M	1.59M	1.43M
Stock-Based Comp., R&D Exp. (Total)	-	-	-	-	-
Stock-Based Comp., G&A Exp. (Total)	2M	2.11M	1.94M	-	2.25M
Stock-Based Comp., SG&A Exp. (Total)	-	-	-	1.47M	-
Total Stock-Based Compensation	4.09M	4.01M	3.7M	3.06M	3.68M

Fiscal Period: December	2020 (USD)	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)
Assets
Cash And Equivalents	35.91M	59.68M	32.73M	35.78M	190M
Short Term Investments	-	-	-	-	-
Total Cash And Short Term Investments	35.91M	59.68M	32.73M	35.78M	190M
Accounts Receivable, Total	11.18M	5.36M	5.83M	16.25M	1.69M
Total Receivables	11.18M	5.36M	5.83M	16.25M	1.69M
Inventory	-	-	-	6.1M	-
Prepaid Expenses	3.07M	4.07M	6.53M	2.73M	12.87M
Restricted Cash	7.04M	2.59M	-	-	6.35M
Total Current Assets	57.19M	71.7M	45.09M	60.86M	211M
Gross Property Plant And Equipment	4.26M	5.77M	4.58M	8.32M	7.31M
Accumulated Depreciation	-3.05M	-3.22M	-3.16M	-3.19M	-3.34M
Net Property Plant And Equipment	1.21M	2.54M	1.43M	5.13M	3.96M
Other Long-Term Assets, Total	2.02M	1.08M	1.07M	1.05M	96K
Total Assets	60.42M	75.32M	47.59M	67.03M	215M
Liabilities
Accounts Payable, Total	4.57M	1.3M	1.45M	3.77M	3.61M
Accrued Expenses, Total	12.17M	15.06M	12.59M	37.25M	44.3M
Current Portion of Long-Term Debt	7.02M	2.59M	-	-	-
Current Portion of Leases	939K	1.15M	1.32M	1.3M	1.64M
Unearned Revenue Current, Total	13.86M	13.92M	14.61M	25.1M	-
Other Current Liabilities	-	-	-	-	-
Total Current Liabilities	38.56M	34.02M	29.97M	67.42M	49.55M
Long-Term Debt	-	-	-	-	-
Long-Term Leases	-	1.32M	-	3.58M	1.93M
Unearned Revenue Non Current	11.14M	18.41M	20.52M	4.24M	-
Other Non Current Liabilities	-	-	-	-	-
Total Liabilities	49.71M	53.75M	50.5M	75.24M	51.49M
Common Stock, Total	4K	7K	7K	9K	1K
Additional Paid In Capital	345M	399M	404M	433M	775M
Retained Earnings	-335M	-377M	-407M	-441M	-611M
Comprehensive Income and Other	-	-	-	-	-
Total Common Equity	10.72M	21.57M	-2.9M	-8.21M	163M
Total Equity	10.72M	21.57M	-2.9M	-8.21M	163M
Total Liabilities And Equity	60.42M	75.32M	47.59M	67.03M	215M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	2.4M	3.41M	4.45M	4.56M	10.95M
ECS Total Common Shares Outstanding	2.24M	3.39M	3.62M	4.53M	10.95M
Book Value / Share	4.78	6.36	-0.8	-1.81	14.92
Tangible Book Value	10.72M	21.57M	-2.9M	-8.21M	163M
Tangible Book Value Per Share	4.78	6.36	-0.8	-1.81	14.92
Total Debt	7.96M	5.06M	1.32M	4.88M	3.58M
Net Debt	-27.95M	-54.62M	-31.41M	-30.9M	-186M
Debt Equivalent Oper. Leases	8M	9.6M	10.4M	12.8M	13.6M
Account Code - Inventory Valuation	3	-	3	3	5
Inventories - Raw Materials, Total	-	-	-	2.69M	-
Inventories - Work In Process, Total	-	-	-	3.41M	-
Machinery, Total	2.97M	3.06M	2.96M	3.32M	3.44M
Full Time Employees	79	89	73	69	38
Part Time Employees	1	-	-	-	-

Fiscal Period: December	2020 (USD)	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)
Net Income	-72.11M	-42.47M	-29.8M	-22.93M	-170M
Depreciation & Amortization - CF	286K	189K	1.22M	118K	233K
Depreciation & Amortization, Total	286K	189K	1.22M	118K	233K
Amortization of Deferred Charges, Total - (CF)	5K	3K	-	77K	184K
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-
Stock-Based Compensation (CF)	4.09M	4.01M	3.53M	3.06M	3.91M
Net Cash From Discontinued Operations	-	-	-	-	1.8M
Other Operating Activities, Total	-41K	-1.41M	1K	1.16M	1.1M
Change In Accounts Receivable	-11.16M	5.82M	-477K	-10.41M	14.28M
Change In Inventories	-	-	-	-6.1M	6.1M
Change In Accounts Payable	6.59M	-1.09M	-2.37M	8.89M	-1M
Change in Unearned Revenues	15.21M	7.32M	2.81M	-5.8M	-29.34M
Change In Income Taxes	-	-	-	6.51M	8M
Change in Other Net Operating Assets	2.73M	2.39M	-3.39M	3M	-11.97M
Cash from Operations	-54.41M	-25.23M	-28.47M	-22.43M	-177M
Capital Expenditure	-186K	-41K	-118K	-505K	-129K
Investment in Marketable and Equity Securities, Total	-	-	-	-	-
Cash from Investing	-186K	-41K	-118K	-505K	-129K
Long-Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	-	-	-	-	-
Long-Term Debt Repaid, Total	-2.96M	-4.44M	-2.59M	-	-276K
Total Debt Repaid	-2.96M	-4.44M	-2.59M	-	-276K
Issuance of Common Stock	40.24M	49.04M	2.36M	25.98M	337M
Repurchase of Common Stock	-	-	-	-	-39K
Issuance of Preferred Stock	-	-	-	-	-
Other Financing Activities, Total	-	-	-720K	-	-
Cash from Financing	37.28M	44.6M	-951K	25.98M	337M
Net Change in Cash	-17.32M	19.32M	-29.54M	3.05M	160M
Supplemental Items
Cash Interest Paid	445K	228K	40K	-	-
Cash Income Tax Paid (Refund)	-	-	-	797K	95K
Levered Free Cash Flow	-35.42M	-13.44M	-15.73M	664K	-67.09M
Unlevered Free Cash Flow	-35.26M	-13.31M	-15.73M	664K	-67.09M
Change In Net Working Capital	-5.45M	-8.94M	1.97M	-13.22M	14.04M
Net Debt Issued / Repaid	-2.96M	-4.44M	-2.59M	-	-276K

Fiscal Period: December	2020 (USD)	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)
Profitability
Return on Assets	-69.41	-38.91	-30.22	-26.72	-40.46
Return on Total Capital	-131.62	-116.57	-148.31	184.81	-69.72
Return On Equity %	-297.06	-263.05	-319.24	202.5	-219.59
Return on Common Equity	-308.44	-263.05	-319.24	202.5	-219.59
Margin Analysis
Gross Profit Margin %	-463.66	-47.44	-17.47	-9.62	-5.54K
SG&A Margin	131.76	37.8	28.75	28.69	1.62K
EBITDA Margin %	-593.05	-84.86	-46	-38.14	-7.14K
EBITA Margin %	-595.42	-85.24	-46.23	-38.31	-7.15K
EBIT Margin %	-595.42	-85.24	-46.23	-38.31	-7.15K
Income From Continuing Operations Margin %	-597.59	-85.67	-46.35	-35.88	-13.36K
Net Income Margin %	-597.59	-85.67	-46.35	-35.88	-13.32K
Net Avail. For Common Margin %	-620.48	-85.67	-46.35	-35.88	-13.36K
Normalized Net Income Margin	-373.49	-53.54	-28.71	-21.99	-4.19K
Levered Free Cash Flow Margin	-293.54	-27.11	-24.47	1.04	-5.26K
Unlevered Free Cash Flow Margin	-292.22	-26.85	-24.47	1.04	-5.26K
Asset Turnover
Asset Turnover	0.19	0.73	1.05	1.12	0.01
Fixed Assets Turnover	7.38	26.42	32.39	19.82	0.28
Receivables Turnover (Average Receivables)	2.16	6	11.49	5.79	0.16
Short Term Liquidity
Current Ratio	1.48	2.11	1.5	0.9	4.25
Quick Ratio	1.22	1.91	1.29	0.77	3.86
Operating Cash Flow to Current Liabilities	-1.41	-0.74	-0.95	-0.33	-3.56
Days Sales Outstanding (Average Receivables)	169.62	60.86	31.76	63.05	2.26K
Average Days Payable Outstanding	17.37	14.65	6.64	-	18.79
Long Term Solvency
Total Debt/Equity	74.31	23.46	-45.35	-59.4	2.19
Total Debt / Total Capital	42.63	19	-82.99	-146.32	2.14
LT Debt/Equity	-	6.13	-	-43.57	1.18
Long-Term Debt / Total Capital	-	4.96	-	-107.32	1.16
Total Liabilities / Total Assets	82.27	71.36	106.1	112.25	23.97
EBIT / Interest Expense	-274.23	-199.32	-	-	-
EBITDA / Interest Expense	-269.32	-192.76	-	-	-
(EBITDA - Capex) / Interest Expense	-270.03	-192.96	-	-	-
Total Debt / EBITDA	-0.11	-0.12	-0.05	-0.21	-0.04
Net Debt / EBITDA	0.4	1.34	1.11	1.36	2.09
Total Debt / (EBITDA - Capex)	-0.11	-0.12	-0.05	-0.21	-0.04
Net Debt / (EBITDA - Capex)	0.4	1.34	1.11	1.33	2.08
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-42.3	310.81	29.69	-0.84	-94.52
Gross Profit, 1 Yr. Growth %	119.53	-57.97	-52.23	-52.54	423.77
EBITDA, 1 Yr. Growth %	72.87	-41.22	-29.69	-26.95	237.71
EBITA, 1 Yr. Growth %	72.2	-41.19	-29.67	-26.92	237.1
EBIT, 1 Yr. Growth %	72.2	-41.19	-29.67	-26.92	237.1
Earnings From Cont. Operations, 1 Yr. Growth %	75.49	-41.11	-29.83	-31.72	578.99
Net Income, 1 Yr. Growth %	75.49	-41.11	-29.83	-31.72	640.6
Normalized Net Income, 1 Yr. Growth %	73.75	-41.11	-30.47	-32.49	240.75
Diluted EPS Before Extra, 1 Yr. Growth %	31.25	-55.06	-46.91	-45.44	367.45
Accounts Receivable, 1 Yr. Growth %	112K	-52.07	8.91	178.52	-87.96
Net Property, Plant and Equip., 1 Yr. Growth %	-41.29	110.17	-43.89	288.12	-22.7
Total Assets, 1 Yr. Growth %	-12.4	24.66	-36.82	41.15	220.45
Tangible Book Value, 1 Yr. Growth %	-71.68	101.33	-113.46	-43.14	-2.09K
Common Equity, 1 Yr. Growth %	-71.68	101.33	-113.46	-43.14	-2.09K
Cash From Operations, 1 Yr. Growth %	90.7	-53.63	12.84	-21.22	686.97
Capital Expenditures, 1 Yr. Growth %	431.43	-77.96	187.8	327.97	-74.46
Levered Free Cash Flow, 1 Yr. Growth %	46.18	-61.22	17.04	-108.69	3.85K
Unlevered Free Cash Flow, 1 Yr. Growth %	45.48	-61.42	18.18	-108.69	3.85K
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	53.95	130.82	13.54	-76.71
Gross Profit, 2 Yr. CAGR %	6.7	-3.94	-55.19	-48.86	225.3
EBITDA, 2 Yr. CAGR %	6.78	0.81	-35.71	-23.88	104.5
EBITA, 2 Yr. CAGR %	6.55	0.63	-35.69	-23.88	104.09
EBIT, 2 Yr. CAGR %	6.55	0.63	-35.69	-23.88	104.09
Earnings From Cont. Operations, 2 Yr. CAGR %	10.54	1.66	-35.72	-26.52	179.99
Net Income, 2 Yr. CAGR %	10.54	1.66	-35.72	-26.52	124.87
Normalized Net Income, 2 Yr. CAGR %	7.1	1.15	-36.01	-27.23	98.35
Diluted EPS Before Extra, 2 Yr. CAGR %	-18.02	-23.2	-51.15	-43.1	107.67
Accounts Receivable, 2 Yr. CAGR %	-	2.21K	-27.75	74.16	-45.57
Net Property, Plant and Equip., 2 Yr. CAGR %	30.36	11.08	8.6	41.99	73.21
Total Assets, 2 Yr. CAGR %	-12.61	4.5	-11.25	-5.67	112.68
Tangible Book Value, 2 Yr. CAGR %	-57.43	-24.49	-47.94	-38.31	236.32
Common Equity, 2 Yr. CAGR %	-57.43	-24.49	-47.94	-38.31	236.32
Cash From Operations, 2 Yr. CAGR %	-2.04	-5.96	-27.66	-5.71	149
Capital Expenditures, 2 Yr. CAGR %	2.51	8.23	-20.35	250.96	4.56
Levered Free Cash Flow, 2 Yr. CAGR %	3.37	-25.52	-32.63	-77.77	607.08
Unlevered Free Cash Flow, 2 Yr. CAGR %	3.12	-25.9	-32.48	-77.66	607.08
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	-	45.4	74.31	-70.48
Gross Profit, 3 Yr. CAGR %	9.32	-21.78	-23.9	-52.1	44.27
EBITDA, 3 Yr. CAGR %	9.14	-12.49	-10.6	-30.17	29.32
EBITA, 3 Yr. CAGR %	8.84	-12.6	-10.69	-30.15	29.24
EBIT, 3 Yr. CAGR %	8.84	-12.6	-10.69	-30.15	29.24
Earnings From Cont. Operations, 3 Yr. CAGR %	8.97	-10.39	-10.16	-31.74	58.87
Net Income, 3 Yr. CAGR %	8.97	-10.39	-10.16	-31.74	58.73
Normalized Net Income, 3 Yr. CAGR %	8.97	-12.26	-10.73	-32.19	26.23
Diluted EPS Before Extra, 3 Yr. CAGR %	-17.29	-32.91	-32.09	-47.39	18.3
Accounts Receivable, 3 Yr. CAGR %	-	-	735.53	13.28	-31.87
Net Property, Plant and Equip., 3 Yr. CAGR %	5.04	52.86	-11.53	61.82	15.94
Total Assets, 3 Yr. CAGR %	-8.56	-1.62	-11.63	3.52	41.81
Tangible Book Value, 3 Yr. CAGR %	-43.61	-28.55	-57.5	-8.49	96.35
Common Equity, 3 Yr. CAGR %	-43.61	-28.55	-57.5	-8.49	96.35
Cash From Operations, 3 Yr. CAGR %	2.92	-23.66	-0.07	-25.57	91.26
Capital Expenditures, 3 Yr. CAGR %	-15.29	-38.59	49.95	39.51	46.53
Levered Free Cash Flow, 3 Yr. CAGR %	5.92	-25.99	-13.41	-73.24	70.9
Unlevered Free Cash Flow, 3 Yr. CAGR %	5.75	-26.24	-13.42	-73.2	71.46
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	-	-	-42.85
Gross Profit, 5 Yr. CAGR %	-	-	-23.48	-34.01	22.6
EBITDA, 5 Yr. CAGR %	17.57	-2.48	-11.69	-17.24	17.06
EBITA, 5 Yr. CAGR %	17.33	-2.69	-11.81	-17.3	16.93
EBIT, 5 Yr. CAGR %	17.33	-2.69	-11.81	-17.3	16.93
Earnings From Cont. Operations, 5 Yr. CAGR %	17.5	-2.49	-11.77	-17.23	32.89
Net Income, 5 Yr. CAGR %	17.5	-2.49	-11.77	-17.23	32.82
Normalized Net Income, 5 Yr. CAGR %	17.5	-2.49	-11.93	-18.58	15.53
Diluted EPS Before Extra, 5 Yr. CAGR %	-11.1	-24.61	-33	-37.18	-0.47
Accounts Receivable, 5 Yr. CAGR %	-	-	-	-	179.11
Net Property, Plant and Equip., 5 Yr. CAGR %	-6.4	13.1	6.45	48.41	13.97
Total Assets, 5 Yr. CAGR %	-11.29	-6.77	-9.65	-3.26	25.51
Tangible Book Value, 5 Yr. CAGR %	-36.52	-24.54	-45.38	-32.63	33.97
Common Equity, 5 Yr. CAGR %	-36.52	-24.54	-45.38	-32.63	33.97
Cash From Operations, 5 Yr. CAGR %	15.95	-8.7	-10.62	-16.93	43.98
Capital Expenditures, 5 Yr. CAGR %	-30.77	-36.62	-17.35	23.33	29.81
Levered Free Cash Flow, 5 Yr. CAGR %	17.86	-9.98	-12	-54.25	22.59
Unlevered Free Cash Flow, 5 Yr. CAGR %	17.72	-10.16	-12.01	-54.26	22.58